Medifast, Inc. MED R2K
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Generates positive free cash flow.
CONS
- Revenue declined at -37.7% CAGR over 5 years.
- Earnings shrank at -37.7% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MED Medifast, Inc. R2K | 12.53 | - | $139.32M | - | -6.93% | -9.80% | -37.74% | -37.67% |
| 2 | AMZN Amazon.com, Inc. NDXSPXAI | 270.64 | 31.65 | $2.91T | - | 16.60% | 24.29% | 11.73% | 984.47% |
| 3 | TSLA Tesla, Inc. NDXSPXAI | 435.79 | 399.81 | $1.64T | - | 5.29% | 4.90% | 5.19% | -32.94% |
| 4 | HD The Home Depot, Inc. SPX | 317.14 | 22.52 | $316.23B | 2.94% | 28.92% | 128.38% | 1.52% | -6.11% |
| 5 | MCD McDonald's Corporation SPX | 279.20 | 23.04 | $198.37B | 2.66% | 22.63% | - | 5.06% | 11.50% |
| 6 | TJX The TJX Companies, Inc. SPX | 154.75 | 30.11 | $171.12B | 1.24% | 32.91% | 61.25% | 6.53% | 16.24% |
| 7 | BKNG Booking Holdings Inc. NDXSPX | 167.43 | 22.09 | $129.74B | 0.96% | 67.24% | - | 16.35% | 20.90% |
| 8 | LOW Lowe's Companies, Inc. SPX | 214.36 | 18.12 | $120.26B | 2.24% | 29.62% | - | -3.85% | 1.11% |
| 9 | PDD PDD Holdings Inc. NDX | 84.44 | 8.87 | $120.19B | - | 28.69% | 25.40% | 49.00% | 45.85% |
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 417.60M | 453.33M | 390.40M | 348.98M | 296.19M | 235.87M | 174.74M | 168.56M | - | 115.73M | 105.56M | 89.41M | 75.10M | 76.04M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.48M | 28.91M | 27.25M | 22.96M | 24.29M |
| Gross Profit | 53.17M | 49.16M | 45.22M | 53.19M | 53.23M | 52.16M | 47.08M | 52.89M | 57.61M | 58.18M | 59.13M | 74.81M | 88.80M | 107.20M | 109.09M | 125.15M | 140.71M | 142.93M | 128.07M | 135.24M | 159.30M | 204.04M | 199.24M | 248.55M | 293.71M | 307.06M | 302.29M | 321.68M | 282.85M | 246.39M | 210.72M | 177.38M | 127.29M | 123.44M | - | 84.25M | 76.64M | 62.16M | 52.14M | 51.76M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 85.51M | 77.71M | 66.24M | 59.94M | 55.05M |
| Operating Income | 8.66M | 7.97M | - | 6.27M | 5.02M | 8.95M | - | 8.61M | 11.31M | 10.23M | - | 14.68M | 17.11M | 17.47M | - | 24.71M | 27.36M | 20.26M | - | 23.53M | 28.10M | 44.56M | - | 52.80M | 61.43M | 55.17M | 55.09M | 48.96M | 48.16M | 53.51M | 38.71M | 25.51M | 7.94M | -7.88M | - | -1.26M | -1.07M | -4.08M | -7.80M | -3.29M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.02M | 2.98M | -629.00K | -4.34M | 188.00K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 526.00K | 2.88M | -2.66M | -6.38M | -1.94M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.30M | 395.00K | -396.00K | 11.74M | 181.00K |
| Net Income | 6.25M | 5.51M | 3.86M | 4.26M | 3.40M | 6.07M | 4.11M | 6.14M | 7.58M | 6.69M | 7.31M | 12.22M | 14.13M | 13.78M | 15.65M | 20.75M | 21.38M | 15.90M | 19.88M | 18.48M | 21.93M | 34.45M | 27.99M | 41.06M | 46.96M | 41.98M | 41.78M | 39.11M | 36.16M | 39.97M | 30.28M | 23.13M | 8.32M | -8.15M | - | -772.00K | 2.48M | -2.26M | -18.12M | -2.12M |
| Diluted EPS | 0.51 | 0.46 | 0.33 | 0.36 | 0.29 | 0.51 | 0.34 | 0.51 | 0.63 | 0.55 | 0.60 | 1.01 | 1.16 | 1.14 | 1.30 | 1.70 | 1.75 | 1.32 | 1.66 | 1.56 | 1.86 | 2.91 | 2.36 | 3.46 | 3.96 | 3.56 | 3.59 | 3.42 | 3.27 | 3.67 | 2.77 | 2.12 | 0.76 | -0.75 | - | -0.07 | 0.22 | -0.21 | -1.65 | -0.19 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.60B | 1.07B | 602.46M | 385.79M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 458.16M | 296.20M | 157.84M | 110.60M |
| Gross Profit | 124.39M | 192.47M | 224.50M | 235.91M | 240.57M | 209.21M | 201.31M | 205.66M | 227.81M | 379.90M | 536.86M | 697.82M | - | 1.14B | 775.85M | 444.62M | 275.19M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 955.61M | 649.45M | 441.75M | 289.40M |
| Operating Income | 18.50M | 31.64M | 27.38M | 27.14M | 38.41M | 30.25M | 28.68M | 26.86M | 39.63M | 69.06M | 91.04M | 134.16M | - | 184.81M | 126.40M | 2.88M | -14.21M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | 195.74M | 139.51M | 15.59M | 29.00K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 701.00K | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 184.06M | 128.80M | 3.79M | -5.64M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 40.49M | 29.38M | 1.70M | 13.03M |
| Net Income | 11.36M | 19.61M | 18.54M | 15.88M | 23.97M | 13.18M | 20.06M | 17.84M | 27.72M | 55.79M | 77.92M | 102.86M | - | 143.57M | 99.42M | 2.09M | -18.67M |
| Diluted EPS | 0.77 | 1.35 | 1.31 | 1.16 | 1.73 | 1.03 | 1.66 | 1.49 | 2.29 | 4.62 | 6.43 | 8.68 | 13.89 | 12.73 | 9.10 | 0.19 | - |
| R&D Expense | - | - | - | - | - | 1.30M | 1.80M | 2.00M | 1.50M | 2.20M | 2.70M | 2.80M | 4.40M | 4.50M | 4.60M | 4.60M | 4.30M |
Compounded Sales Growth
| 5 Years: | -37.74% |
| 1 Year: | -34.30% |
Compounded Profit Growth
| 5 Years: | -37.67% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -10.95% |
| 6 Months: | +14.85% |
| 3 Months: | +18.99% |
| 1 Month: | +14.74% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 94.06M | 105.67M | 130.25M | 132.65M | 115.91M | 116.12M | 121.22M | 145.93M | 169.43M | 194.65M | 276.08M | - | 316.21M | 309.91M | 284.21M | 247.97M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 222.78M | 224.03M | 214.40M | 201.68M |
| Cash & Equivalents | 973.00K | 10.60M | 17.16M | 14.26M | 39.94M | 36.38M | 24.46M | 42.04M | 52.44M | 75.08M | 81.36M | 76.97M | 163.72M | - | 87.69M | 94.44M | 90.93M | 89.30M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 118.86M | 54.59M | 42.42M | 20.23M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | 22.10M | 32.26M | 39.47M | 34.23M | 35.43M | 27.53M | 25.20M | 37.35M | 60.32M | 89.82M | 118.84M | - | 161.17M | 108.43M | 74.10M | 49.05M |
| Current Liabilities | - | - | 15.96M | 20.26M | 28.75M | 27.10M | 26.94M | 23.56M | 24.42M | 37.14M | 60.32M | 79.39M | 111.35M | - | 140.89M | 92.30M | 64.16M | 42.96M |
| Long Term Debt | - | - | 4.65M | 3.34M | 3.11M | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.05M | 22.01M | 16.12M | 10.69M |
| Total Equity | 34.07M | 47.82M | 71.96M | 73.40M | 90.79M | 98.42M | 80.48M | 88.58M | 96.02M | 106.56M | 109.11M | 104.83M | 157.25M | - | 155.04M | 201.48M | 210.11M | 198.92M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.93M | 10.90M | 10.94M | 10.99M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 19.16M | 28.77M | 34.87M | 40.26M | 42.36M | 25.54M | 29.41M | 25.35M | 43.24M | 60.82M | 84.26M | 145.20M | - | 194.57M | 147.66M | 24.48M | 6.86M |
| Investing Cash Flow | -8.62M | -23.54M | -16.87M | -11.66M | -22.60M | -2.52M | -189.00K | -2.04M | -3.16M | -1.20M | -6.33M | -1.28M | - | -11.41M | -61.05M | -26.52M | -7.93M |
| Financing Cash Flow | -908.00K | 1.33M | -20.90M | -2.92M | -23.31M | -34.94M | -11.73M | -12.92M | -17.36M | -53.33M | -82.32M | -57.14M | - | -199.58M | -79.79M | -1.51M | -564.00K |
| Capital Expenditure | -5.12M | -12.05M | -14.27M | -8.13M | -11.39M | -7.02M | -2.82M | -2.88M | -3.24M | -4.94M | -10.06M | -5.89M | - | -16.68M | -6.48M | -7.45M | -5.61M |
| Free Cash Flow | 14.04M | 16.71M | 20.60M | 32.14M | 30.97M | 18.51M | 26.59M | 22.47M | 39.99M | 55.88M | 74.20M | 139.31M | - | 177.89M | 141.17M | 17.02M | 1.25M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | -16.43M | 6.82M | -3.56M | -1.63M |
| Share Buybacks | 102.00K | 35.00K | 20.39M | 2.76M | 20.08M | 33.89M | 10.52M | - | - | 30.00M | 33.11M | 5.00M | 56.00M | 126.44M | 3.60M | 0 | 0 |
| Dividends Paid | - | - | - | - | - | - | - | 11.89M | 15.39M | 23.16M | 35.40M | 53.19M | 63.86M | 71.62M | 73.02M | 715.00K | 195.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 71.3% | 72.4% | 73.8% | 71.3% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.6% | 11.8% | 0.5% | -3.7% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.0% | 9.3% | 0.3% | -4.8% |
| ROE % | 23.8% | 27.3% | 25.3% | 17.5% | 24.4% | 16.4% | 22.6% | 18.6% | 26.0% | 51.1% | 74.3% | 65.4% | - | 92.6% | 49.3% | 1.0% | -9.4% |
| ROCE % | - | 40.5% | 32.1% | 26.7% | 36.4% | 34.0% | 31.0% | 27.7% | 36.4% | 63.3% | 79.0% | 81.4% | - | 105.4% | 58.1% | 1.3% | -6.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.49% | 944.45K | $11.83M |
| 2 | Renaissance Technologies, LLC | 6.96% | 773.71K | $9.69M |
| 3 | Steamboat Capital Partners, Llc | 6.36% | 707.59K | $8.87M |
| 4 | Charles Schwab Investment Management, Inc. | 5.68% | 631.54K | $7.91M |
| 5 | Vanguard Capital Management LLC | 4.00% | 444.47K | $5.57M |
| 6 | Dimensional Fund Advisors LP | 3.25% | 361.76K | $4.53M |
| 7 | Two Sigma Investments, LP | 3.04% | 338.16K | $4.24M |
| 8 | Morgan Stanley | 2.93% | 325.31K | $4.08M |
| 9 | Geode Capital Management, LLC | 2.28% | 253.31K | $3.17M |
| 10 | Man Group PLC | 2.12% | 236.21K | $2.96M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MED